Log In
BCIQ
Print this Print this
 

CA 15-3 radioimmunoassay

  Manage Alerts
Collapse Summary General Information
Company Fujirebio Inc.
DescriptionCA 15-3 radioimmunoassay for detection of breast cancer
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsEarly detection of breast cancer recurrence
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today